SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
Conclusion: Differential SOX4 expression presents an avenue of diagnosing and predicting clinical course of HCC. In HCC, SOX4 may affect TP53 metabolic processes, lymphocyte differentiation and the insulin signaling pathway.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Jian-Lv Huang, Xiang-Kun Wang, Xi-Wen Liao, Chuang-Ye Han, Ting-Dong Yu, Ke-Tuan Huang, Cheng-Kun Yang, Xiao-Guang Liu, Long Yu, Guang-Zhi Zhu, Hao Su, Wei Qin, Quan-Fa Han, Zheng-Qian Liu, Xin Zhou, Jun-Qi Liu, Xin-Ping Ye, Tao Peng Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Insulin | Liver | Liver Cancer | Liver Disease | Pancreas | Pancreatic Cancer | Study | Urology & Nephrology | Websites